Literature DB >> 29507029

Encephalopathy in an adult with cat-scratch disease.

Michael Samarkos1,2, Vasiliki Antoniadou1, Aristeidis G Vaiopoulos2, Mina Psichogiou1,2.   

Abstract

We report the case of a 53-year-old healthy man, presenting with confusion. The patient had been clinically diagnosed with cat-scratch disease (CSD) and prescribed a 10-day course of doxycycline orally. Approximately a week after he had completed the treatment, he was admitted to our department with confusion. Neurological examination revealed expressive dysphasia with no motor or sensory deficits. Cerebrospinal fluid (CSF) examination showed only increased content. Imaging with CT and MRI of the brain did not reveal any abnormalities, and funduscopy was normal. Serology confirmed Bartonella henselae infection. CSD-associated encephalopathy was confirmed based on the clinical manifestations, CSF findings and positive serology. The patient was treated with a combination of doxycycline and rifampin and he rapidly improved with complete neurological recovery within 7 days. Encephalopathy is an unusual manifestation of CSD in adults with excellent prognosis. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  accidents; coma and raised intracranial pressure; infection (neurology); infectious diseases; injuries; neurological injury

Mesh:

Substances:

Year:  2018        PMID: 29507029      PMCID: PMC5847957          DOI: 10.1136/bcr-2017-223647

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Cat scratch disease: analysis of 130 seropositive cases.

Authors:  Kyoko Murakami; Masato Tsukahara; Hidehiro Tsuneoka; Hidechika Iino; Chizuru Ishida; Kumiko Tsujino; Akiko Umeda; Tomoko Furuya; Shigeto Kawauchi; Kohsuke Sasaki
Journal:  J Infect Chemother       Date:  2002-12       Impact factor: 2.211

Review 2.  Recommendations for treatment of human infections caused by Bartonella species.

Authors:  J M Rolain; P Brouqui; J E Koehler; C Maguina; M J Dolan; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

3.  New-onset refractory status epilepticus in an adult with an atypical presentation of cat-scratch disease: successful treatment with high-dose corticosteroids.

Authors:  Emily M Laswell; Kasandra D Chambers; Danielle R Whitsel; Kiran Poudel
Journal:  Pharmacotherapy       Date:  2015-06-04       Impact factor: 4.705

4.  Neurologic manifestations of cat-scratch disease. Report of a case and review of the literature.

Authors:  L W Lyon
Journal:  Arch Neurol       Date:  1971-07

5.  Cat-scratch disease in elderly patients.

Authors:  Ronen Ben-Ami; Moshe Ephros; Boaz Avidor; Eugene Katchman; Merav Varon; Cecilia Leibowitz; Doron Comaneshter; Michael Giladi
Journal:  Clin Infect Dis       Date:  2005-08-30       Impact factor: 9.079

6.  Cat-scratch disease. An overview based on a study of 1,200 patients.

Authors:  H A Carithers
Journal:  Am J Dis Child       Date:  1985-11

7.  Cat scratch disease encephalopathy in an immunocompetent patient.

Authors:  P Dyachenko; M Ziv; R Raz; B Chazan; A Lev; D Rozenman
Journal:  Eur J Intern Med       Date:  2005-12       Impact factor: 4.487

Review 8.  Neurologic complications of Bartonella henselae infection.

Authors:  C M Marra
Journal:  Curr Opin Neurol       Date:  1995-06       Impact factor: 5.710

9.  Encephalitis associated with cat scratch disease--Broward and Palm Beach Counties, Florida, 1994.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1994-12-16       Impact factor: 17.586

10.  Cat-Scratch Disease in the United States, 2005-2013.

Authors:  Christina A Nelson; Shubhayu Saha; Paul S Mead
Journal:  Emerg Infect Dis       Date:  2016-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.